17 reports of this reaction
3.2% of all ESMOLOL HYDROCHLORIDE reports
#4 most reported adverse reaction
BRADYCARDIA is the #4 most commonly reported adverse reaction for ESMOLOL HYDROCHLORIDE, manufactured by Baxter Healthcare Corporation. There are 17 FDA adverse event reports linking ESMOLOL HYDROCHLORIDE to BRADYCARDIA. This represents approximately 3.2% of all 539 adverse event reports for this drug.
Patients taking ESMOLOL HYDROCHLORIDE who experience bradycardia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BRADYCARDIA is moderately reported among ESMOLOL HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to bradycardia, the following adverse reactions have been reported for ESMOLOL HYDROCHLORIDE:
The following drugs have also been linked to bradycardia in FDA adverse event reports:
BRADYCARDIA has been reported as an adverse event in 17 FDA reports for ESMOLOL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
BRADYCARDIA accounts for approximately 3.2% of all adverse event reports for ESMOLOL HYDROCHLORIDE, making it a notable side effect.
If you experience bradycardia while taking ESMOLOL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.